ES3040905T3 - Nanocapsules comprising a liposoluble active ingredient, production and uses - Google Patents

Nanocapsules comprising a liposoluble active ingredient, production and uses

Info

Publication number
ES3040905T3
ES3040905T3 ES17715241T ES17715241T ES3040905T3 ES 3040905 T3 ES3040905 T3 ES 3040905T3 ES 17715241 T ES17715241 T ES 17715241T ES 17715241 T ES17715241 T ES 17715241T ES 3040905 T3 ES3040905 T3 ES 3040905T3
Authority
ES
Spain
Prior art keywords
nanocapsules
ionic surfactant
vitamin
colloidal suspension
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17715241T
Other languages
English (en)
Spanish (es)
Inventor
Damien Preveraud
Véronique Rosilio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adisseo France SAS
Original Assignee
Adisseo France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56263861&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES3040905(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adisseo France SAS filed Critical Adisseo France SAS
Application granted granted Critical
Publication of ES3040905T3 publication Critical patent/ES3040905T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Colloid Chemistry (AREA)
  • Fodder In General (AREA)
  • General Preparation And Processing Of Foods (AREA)
ES17715241T 2016-03-25 2017-03-17 Nanocapsules comprising a liposoluble active ingredient, production and uses Active ES3040905T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1652592 2016-03-25
PCT/FR2017/050622 WO2017162963A1 (fr) 2016-03-25 2017-03-17 Nanocapsules de principe actif liposoluble, fabrication et utilisations

Publications (1)

Publication Number Publication Date
ES3040905T3 true ES3040905T3 (en) 2025-11-05

Family

ID=56263861

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17715241T Active ES3040905T3 (en) 2016-03-25 2017-03-17 Nanocapsules comprising a liposoluble active ingredient, production and uses

Country Status (14)

Country Link
US (1) US10765639B2 (enExample)
EP (1) EP3432729B1 (enExample)
JP (1) JP2019513359A (enExample)
KR (1) KR20180128025A (enExample)
CN (1) CN108882729A (enExample)
AU (1) AU2017236312B2 (enExample)
BR (1) BR112018069392B1 (enExample)
CA (1) CA3017931C (enExample)
ES (1) ES3040905T3 (enExample)
MX (1) MX2018011620A (enExample)
RU (1) RU2745844C2 (enExample)
UA (1) UA127243C2 (enExample)
WO (1) WO2017162963A1 (enExample)
ZA (1) ZA201806197B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102370217B1 (ko) * 2019-11-27 2022-03-07 군산대학교 산학협력단 유자 오일을 포함하는 나노복합체의 제조방법
RU2736051C1 (ru) * 2020-03-04 2020-11-11 Александр Александрович Кролевец Способ получения нанокапсул сухого экстракта эхинацеи
RU2743010C1 (ru) * 2020-03-23 2021-02-12 Таисия Скандарбековна Гутнова Способ получения нанокапсул витамина D3
CN114847488A (zh) * 2022-05-17 2022-08-05 江南大学 一种高稳定性和生物可给率的橘味维生素a-维生素d纳米复合载体制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788007B1 (fr) 1999-01-05 2001-02-09 Oreal Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
FR2803203B1 (fr) 1999-12-31 2002-05-10 Fournier Ind & Sante Nouvelles formulations galeniques du fenofibrate
FR2806005B1 (fr) * 2000-03-10 2002-06-14 Univ Claude Bernard Lyon Procede de preparation de particules colloidales sous forme de nanocapsules
FR2814380B1 (fr) * 2000-09-25 2002-11-08 Serobiologiques Lab Sa Poudre de microcapsules et procede d'obtention
JP2005028559A (ja) * 2003-07-08 2005-02-03 Shinobu Ito ナノカプセル
FR2864900B1 (fr) * 2004-01-09 2007-10-12 Oreal Dispersion aqueuse de nanocapsules a coeur huileux
WO2007046632A1 (en) * 2005-10-18 2007-04-26 Amorepacific Corporation Cationic polymer nanoparticles encapsulating an active ingredients, and the cosmetic composition containing the same
PT1834635E (pt) 2006-03-13 2011-10-13 Advanced In Vitro Cell Technologies S L Sistemas estáveis de nanocápsula para a administração de moléculas activas
FR2924943A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition dermatologique comprenant des nanocapsules polymeriques de calcitriol, son procede de preparation et son utilisation
BRPI0805854A2 (pt) 2008-10-10 2010-08-24 Biolab Sanus Farmaceutica Ltda sistema nanoparticulado, processo de preparaÇço do mesmo, uso do mesmo, composiÇço fotoproterora, processo de preparaÇço da mesma, mÉtodo de prevenÇço de doenÇas e distérbios da pele
KR20160148041A (ko) * 2009-04-24 2016-12-23 아이슈티카 피티와이 리미티드 캅셀화된 나노입자의 상업적 규모의 생산
EP2266546A1 (en) * 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Process for the preparation of colloidal systems for the delivery of active compounds
ES2351756B1 (es) * 2009-07-28 2011-10-05 Universidad Del Pais Vasco Nanopartículas lipídicas para terapia génica.
CA2843943A1 (en) * 2014-02-20 2014-05-28 Pankaj Modi Oral formulations of chemotherapeutic agents
RU2557900C1 (ru) * 2014-03-25 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул витаминов
US10391060B2 (en) * 2015-08-06 2019-08-27 Rubicon Research Private Limited Particulate delivery systems

Also Published As

Publication number Publication date
BR112018069392A2 (pt) 2019-01-22
UA127243C2 (uk) 2023-06-21
JP2019513359A (ja) 2019-05-30
CA3017931C (fr) 2024-01-09
AU2017236312A1 (en) 2018-10-18
CA3017931A1 (fr) 2017-09-28
KR20180128025A (ko) 2018-11-30
RU2018135575A (ru) 2020-04-27
RU2018135575A3 (enExample) 2020-06-09
US20190083414A1 (en) 2019-03-21
WO2017162963A1 (fr) 2017-09-28
EP3432729A1 (fr) 2019-01-30
EP3432729B1 (fr) 2025-08-13
MX2018011620A (es) 2019-03-14
AU2017236312B2 (en) 2021-02-04
ZA201806197B (en) 2019-06-26
BR112018069392B1 (pt) 2022-11-22
CN108882729A (zh) 2018-11-23
US10765639B2 (en) 2020-09-08
RU2745844C2 (ru) 2021-04-01

Similar Documents

Publication Publication Date Title
Kharat et al. Comparison of emulsion and nanoemulsion delivery systems: The chemical stability of curcumin decreases as oil droplet size decreases
Zou et al. Characterization and bioavailability of tea polyphenol nanoliposome prepared by combining an ethanol injection method with dynamic high-pressure microfluidization
CN101534796B (zh) 含有生理活性物质的粒状组合物及其制备方法
US9655849B2 (en) Solid particulate compositions comprising coenzyme Q10
JP2016539161A (ja) 好ましくは親油性活性物質を含む脂質マイクロカプセル、並びにそれを含有する組成物、それらの製造のための方法、並びに皮膚科学及び化粧品におけるそれらの使用
KR20200040756A (ko) 안정한 카나비노이드 조성물
EP3280398A1 (en) Self-emulsifying formulations of dim-related indoles
Abolmaali et al. Pharmaceutical Nanoemulsions and Their Potential Topical and Transdermal Applications: Pharmaceutical nanoemulsions potential applications
US20180036248A1 (en) Curcumin solid lipid particles and methods for their preparation and use
WO2016083874A1 (en) Stable oil suspensions comprising lipophilic nutrient with enhanced bioavailability and process of preparation
Zheng et al. Improving in vitro bioaccessibility and bioactivity of carnosic acid using a lecithin-based nanoemulsion system
AU2017236312B2 (en) Nanocapsules comprising a liposoluble active ingredient, production and uses
JP6618488B2 (ja) テストステロンウンデカノエートの安定な製剤
CN103732255B (zh) 软胶囊制剂、软胶囊制剂用组合物及软胶囊制剂的制造方法
WO2020203809A1 (ja) レシチンｓ／ｏ製剤の新規製造方法及びその製剤
EP3181125B1 (en) Capsule formulation
JPWO2021005676A1 (ja) マイクロエマルションを調製するための組成物、マイクロエマルション、これらの製造方法、及びマイクロエマルションの利用
ES2965914T3 (es) Micelas de succinato 1000 de polietilenglicol de d-alfa-tocoferilo
JP2021011467A (ja) マイクロエマルション、及びマイクロエマルションの利用
WO2023054704A1 (ja) 水溶性化合物とレシチンからなる複合体油中分散液の製造方法
Ha et al. Preparation of Essential Oil Nanoemulsion With Cellulose Derivatives
Shakeri et al. Co-encapsulation of omega-3
JP2020083806A (ja) ビタミンｅ含有油性組成物
LT6699B (lt) Proliposomų gamybos būdas, naudojant ne daugiau kaip 5 % etanolio, ir jų panaudojimas lipofilinių medžiagų kapsuliavimui
WO2019063863A1 (es) Método para la obtención de microcápsulas, microcápsulas obtenidas mediante el mismo, y composiciones nutracéuticas o farmacéuticas que comprenden dichas microcápsulas